Bronte Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.1M | Buy |
295,346
+32,947
| +13% | +$4.7M | 3.31% | 12 |
|
|
2025
Q1 | $39.3M | Sell |
262,399
-2,187
| -0.8% | -$327K | 3.19% | 12 |
|
|
2024
Q4 | $41M | Sell |
264,586
-8,369
| -3% | -$1.3M | 3.24% | 11 |
|
|
2024
Q3 | $39.7M | Buy |
272,955
+512
| +0.2% | +$74.5K | 3.23% | 12 |
|
|
2024
Q2 | $37.4M | Sell |
272,443
-10,977
| -4% | -$1.51M | 2.93% | 13 |
|
|
2024
Q1 | $38.9M | Buy |
283,420
+1,892
| +0.7% | +$260K | 3.17% | 11 |
|
|
2023
Q4 | $38.2M | Sell |
281,528
-1,701
| -0.6% | -$231K | 3.42% | 11 |
|
|
2023
Q3 | $34.6M | Sell |
283,229
-44,584
| -14% | -$5.45M | 3.49% | 12 |
|
|
2023
Q2 | $41.6M | Buy |
327,813
+25,737
| +9% | +$3.27M | 4.01% | 7 |
|
|
2023
Q1 | $39M | Buy |
302,076
+44,461
| +17% | +$5.74M | 4.53% | 8 |
|
|
2022
Q4 | $33.8M | Sell |
257,615
-5,476
| -2% | -$719K | 4.27% | 10 |
|
|
2022
Q3 | $30.8M | Sell |
263,091
-21,178
| -7% | -$2.48M | 3.83% | 10 |
|
|
2022
Q2 | $33.4M | Buy |
+284,269
| New | +$33.4M | 3.83% | 8 |
|